XML 69 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Balance Sheets (USD $)
Jun. 30, 2013
Sep. 30, 2012
CURRENT ASSETS    
Cash and cash equivalents $ 29,025,930 $ 3,377,288
Trade receivable   9,375
Other receivables 267,560 9,930
Prepaid expenses and other current assets 1,059,503 618,130
Short term investments 4,058,003 106,500
Note receivable, net   2,446,113
TOTAL CURRENT ASSETS 34,410,996 6,567,336
PROPERTY AND EQUIPMENT    
Computers, office equipment and furniture 323,376 323,376
Research equipment 3,346,789 3,319,027
Software 69,623 69,623
Leasehold improvements 2,749,409 2,749,409
Property, Plant and Equipment, Gross, Total 6,489,197 6,461,435
Less: Accumulated depreciation and amortization (2,695,886) (1,565,783)
PROPERTY AND EQUIPMENT, NET 3,793,311 4,895,652
OTHER ASSETS    
Patents and other intangible assets, net 3,254,177 4,784,569
Derivative asset and other non-current assets 30,011 280,261
TOTAL OTHER ASSETS 3,284,188 5,064,830
TOTAL ASSETS 41,488,495 16,527,818
CURRENT LIABILITIES    
Accounts payable 1,061,944 877,986
Accrued expenses 706,092 730,775
Accrued payroll and benefits 811,046 1,127,219
Deferred revenue 71,875 37,500
Derivative liabilities 2,335,163 647,213
Capital lease obligation 219,690 214,801
Notes payable 925,649 100,000
Other current liabilities 546,407 1,592,394
TOTAL CURRENT LIABILITIES 6,677,866 5,327,888
LONG-TERM LIABILITIES    
Notes payable, net of current portion 50,000 839,421
Capital lease obligation, net of current portion 1,117,074 1,282,458
Other non-current liabilities 337,587 269,142
TOTAL LONG-TERM LIABILITIES 1,504,661 2,391,021
Commitments and contingencies      
STOCKHOLDERS’ EQUITY    
Preferred stock, $0.001 par value; 5,000,000 shares authorized; 9,900 shares issued and outstanding 10  
Common stock, $0.001 par value; 145,000,000 shares authorized; 31,306,318 and 13,579,185 shares issued and outstanding as of June 30, 2013 and September 30, 2012, respectively 123,665 108,354
Additional paid-in capital 187,282,079 145,917,968
Subscription receivable   (1,016,000)
Accumulated deficit during the development stage (152,448,785) (134,997,680)
Total Arrowhead Research Corporation stockholders' equity 34,956,969 10,012,642
Noncontrolling interest (1,651,001) (1,203,733)
TOTAL STOCKHOLDERS’ EQUITY 33,305,968 8,808,909
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 41,488,495 $ 16,527,818